1786 (1786) News
Follow 1786 (1786) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
SciVision Biotech Reports 2Q Net Profit of NT$34.6M
SciVision Biotech reported second-quarter net profit of NT$34.6 million, compared with a net loss of NT$16.0 million a year earlier. Revenue was NT$211.026 million versus NT$209.487 million.
EARNINGS | Oct 28, 2026, 09:42 AM UTC
M
SciVision Biotech Reports 1Q Net Profit of NT$22.0 Million
SciVision Biotech reported first-quarter net profit of NT$22.0 million, unchanged from the year-earlier quarter. Revenue was NT$205.322 million and pretax profit was NT$35.682 million in both periods.
EARNINGS | Oct 28, 2026, 09:40 AM UTC
M
SciVision Biotech Reports FY Net Profit of NT$162.3 Million
SciVision Biotech reported net profit of NT$162.3 million for the 12 months ended Dec. 31, versus NT$242.3 million a year earlier.
EARNINGS | Oct 28, 2026, 09:39 AM UTC
M
SciVision Biotech reports Sep revenue NT$61.1M
SciVision Biotech Inc. reported September revenue of NT$61,102,000 versus NT$60,337,000, and Jan–Sep revenue of NT$619,019,000 versus NT$635,232,000, per Taiwan Stock Exchange figures.
EARNINGS | Oct 08, 2026, 08:56 AM UTC
L
SciVision Biotech Aug revenue falls to NT$66.4M vs NT$85.9M
SciVision Biotech reported August revenue of NT$66,363,000 versus NT$85,888,000 in 2025. Jan-Aug revenue was NT$557,917,000 versus NT$574,895,000 in 2025, Taiwan Stock Exchange data.
EQUITY | Sep 08, 2026, 08:47 AM UTC